Scientific publications
Authors' Response
Jun 4, 2015
| Magazine: American Journal of Haematology
Mateos MV(1), Shi H(2), San Miguel JF(3).
Comment on
Effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib-melphalan-prednisone in the phase III VISTA study. [Am J Hematol. 2015]
Immortal time bias and reverse causality in retrospective analysis: Comment on "effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib-melphalan-prednisone in the phase III VISTA study". [Am J Hematol. 2015]
CITATION Am J Hematol. 2015 Aug;90(8):E146. doi: 10.1002/ajh.24079.